Skip to main content

Main menu

  • Home
  • Articles
    • Current Issue
    • Next in The JI
    • Archive
    • Brief Reviews
    • Pillars of Immunology
    • Translating Immunology
    • Most Read
    • Top Downloads
    • Annual Meeting Abstracts
  • COVID-19/SARS/MERS Articles
  • Info
    • About the Journal
    • For Authors
    • Journal Policies
    • Influence Statement
    • For Advertisers
  • Editors
  • Submit
    • Submit a Manuscript
    • Instructions for Authors
    • Journal Policies
  • Subscribe
    • Journal Subscriptions
    • Email Alerts
    • RSS Feeds
    • ImmunoCasts
  • More
    • Most Read
    • Most Cited
    • ImmunoCasts
    • AAI Disclaimer
    • Feedback
    • Help
    • Accessibility Statement
  • Other Publications
    • American Association of Immunologists
    • ImmunoHorizons

User menu

  • Subscribe
  • Log in

Search

  • Advanced search
The Journal of Immunology
  • Other Publications
    • American Association of Immunologists
    • ImmunoHorizons
  • Subscribe
  • Log in
The Journal of Immunology

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Next in The JI
    • Archive
    • Brief Reviews
    • Pillars of Immunology
    • Translating Immunology
    • Most Read
    • Top Downloads
    • Annual Meeting Abstracts
  • COVID-19/SARS/MERS Articles
  • Info
    • About the Journal
    • For Authors
    • Journal Policies
    • Influence Statement
    • For Advertisers
  • Editors
  • Submit
    • Submit a Manuscript
    • Instructions for Authors
    • Journal Policies
  • Subscribe
    • Journal Subscriptions
    • Email Alerts
    • RSS Feeds
    • ImmunoCasts
  • More
    • Most Read
    • Most Cited
    • ImmunoCasts
    • AAI Disclaimer
    • Feedback
    • Help
    • Accessibility Statement
  • Follow The Journal of Immunology on Twitter
  • Follow The Journal of Immunology on RSS

Altered Self, Altered World

Michael J. Bevan
J Immunol September 1, 2004, 173 (5) 2897-2898; DOI: https://doi.org/10.4049/jimmunol.173.5.2897
Michael J. Bevan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
  • PDF
Loading

Throughout the 1960s and early 1970s, it was apparent to immunologists that the products of the MHC had a profound influence on immune responsiveness. So-called Ir genes that mapped within the MHC controlled the level of response, high vs low, to certain simple Ags. Another intriguing and well-studied finding—and the easiest T cell response to study in those days—was the whopping reaction of T cells from one individual to the inactivated cells of another member of the species, provided that the responder and stimulator differed at the MHC, a phenomenon referred to as “alloreactivity.” However, no one understood how the effects of MHC genes were mediated, nor why the MHC genes were the most polymorphic loci known.

Toward the end of this age of darkness, results began to appear suggesting that the MHC also controlled Ag-specific interactions between T cells and other cells such as B lymphocytes and APCs. Benacerraf, Kindred, and their colleagues’ investigations of T:B interactions, and Shevach and Rosenthal’s studies of T:macrophage interactions, had provided evidence for the control of these cellular interactions by the MHC. In April 1974, Rolf Zinkernagel and Peter Doherty, at the John Curtin School in Canberra, Australia, published their finding that CTLs from lymphocytic choriomeningitis virus-infected mice would only kill infected target cells that shared MHC type with the responder strain (1). The beauty of this report was that the restriction could be observed in a simple, short, in vitro chromium-release assay involving only T cells and fibroblast targets, but the real bombshell came from Zinkernagel and Doherty 6 months later, when they proposed that the explanation for the MHC restriction was that T cells recognize self-MHC molecules that have been altered in some way by infection or Ag. The altered self hypothesis was born (2).

The paper in Nature of August 1974 presented some evidence to support this novel interpretation for the MHC restriction of T cell function. It was known that MHC heterozygous CTL could interact with and kill target cells from either parent. Thus, CTL from an infected AxB mouse killed infected A targets and infected B targets, but not infected C or infected D targets. Zinkernagel and Doherty reasoned that an “intimacy” model, which required T cells to share self-MHC markers with targets, could explain this pattern of specificity. For example, there could be a requirement for a like:like interaction between MHC molecules on the T cell and its target. The virus-specific receptor on the T cell would be separate from this intimacyreceptor, and in all likelihood, the same AxB CTL that killed infected A targets would also kill infected B targets. In contrast, the altered self hypothesis predicted that virus modified the A and B MHC molecules differently and that the receptor on the T cell would be different for each complex and clonally distributed, such that the T cells recognizing infected A targets would be different from those recognizing infected B targets. The experiment aimed at discriminating these two ideas took primed CTL from an AxB mouse and restimulated them on virus-infected presenting cells of either parent A or parent B before assaying the levels of killing against infected A or infected B targets. The results supported the idea that the T cell repertoire contains separate pools of T cells that see Ag in association with each MHC type. The results did not prove the altered self hypothesis because, as the authors pointed out, intimacy receptors for self-MHC could also be distributed clonally on T cells. Nevertheless, the altered self hypothesis just felt correct. For many of us, it was a blinding insight that explained all of the MHC-associated immune phenomena.

It even went further. If T cells bore receptors that were specific for foreign Ag only when seen in the context of a self-MHC molecule, the hypothesis predicted that T cells had found a way to ignore any form of Ag not associated with the surface of a relevant presenting cell, whether it was a target to kill or a B lymphocyte to help. It was the job of Ab to bind and neutralize Ag, and the job of T cells to engage in cell:cell interactions and not be diverted by binding free Ag.

Over the years that followed, it was realized that Th cells, now referred to as CD4 T cells, recognize Ag-plus MHC class II molecules, which are selectively expressed on B cells, dendritic cells, macrophages, and a few other locations. In contrast, CTLs, or CD8 T cells, recognize Ag in association with MHC class I molecules, which are widely expressed, as one would expect, to allow any infected cell to be targeted for cytolysis. The altered self model of T cell recognition also led to the realization that the repertoire of TCRs present in any individual is selected by self-MHC molecules in the thymus to be the assortment of receptors best able to interact with Ag-altered self. It would be quite a few more years before the nature of the alteration of self-MHC by Ag was discovered or the precise pathway of positive selection was revealed. However, MHC restriction of T cell recognition, and the altered self interpretation set the stage for this subsequent work. Who could have predicted that MHC molecules would turn out to be peptide binding grooves that (due to their polymorphism) determine which fragments of protein Ags are presented to T cells? With this elucidation of the nature of altered self came the insight that the universe of Ags for T cells was roughly divisible into two separate sources: exogenous Ag, degraded into peptides for class II binding in endosomes to be perused by CD4 T cells, and endogenous or cellular Ag, processed by proteasomes for MHC class I binding and surveillance by CD8 killer cells.

This was the future, and 1974 was the beginning of the revolution. For me it was the most intellectually exciting time to argue and debate with colleagues at the Salk Institute, Mel Cohn, Rod Langman, and Polly Matzinger, about the implications of MHC restriction. It was no surprise when Peter and Rolf were awarded the Nobel Prize for Physiology and Medicine in 1996 for their classic work.

Footnotes

  • ↵1 Address correspondence and reprint requests to Dr. Michael J. Bevan, Department of Immunology and Howard Hughes Medical Institute, University of Washington, Box 357370, Seattle, WA 98195. E-mail address: mbevan{at}u.washington.edu

  • Copyright © 2004 by The American Association of Immunologists

References

  1. ↵
    Zinkernagel, R. M., P. C. Doherty. 1974. Restriction of in vivo T cell-mediated cytotoxicity in lymphocytic choriomeningitis within a syngeneic or semiallogeneic system. Nature 248:701.
    OpenUrlCrossRefPubMed
  2. ↵
    Zinkernagel, R. M., P. C. Doherty. 1974. Immunological surveillance against altered self components by sensitised T lymphocytes in lymphocytic choriomeningitis. Nature 251:547.
    OpenUrlCrossRefPubMed
PreviousNext
Back to top

In this issue

The Journal of Immunology: 173 (5)
The Journal of Immunology
Vol. 173, Issue 5
1 Sep 2004
  • Table of Contents
  • About the Cover
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word about The Journal of Immunology.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Altered Self, Altered World
(Your Name) has forwarded a page to you from The Journal of Immunology
(Your Name) thought you would like to see this page from the The Journal of Immunology web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Altered Self, Altered World
Michael J. Bevan
The Journal of Immunology September 1, 2004, 173 (5) 2897-2898; DOI: 10.4049/jimmunol.173.5.2897

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Altered Self, Altered World
Michael J. Bevan
The Journal of Immunology September 1, 2004, 173 (5) 2897-2898; DOI: 10.4049/jimmunol.173.5.2897
del.icio.us logo Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like

Jump to section

  • Article
    • Footnotes
    • References
  • Info & Metrics
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • Nucleic Acid Sensing and Systemic Lupus Erythematosus: The Danger of Self
  • Long Live the Plasma Cell: The Basis of Sustained Humoral Immunity
  • CCR5: The Receptor That Unlocks the Door for HIV Entry into Cells
Show more Pillars of Immunology

Similar Articles

Navigate

  • Home
  • Current Issue
  • Next in The JI
  • Archive
  • Brief Reviews
  • Pillars of Immunology
  • Translating Immunology

For Authors

  • Submit a Manuscript
  • Instructions for Authors
  • About the Journal
  • Journal Policies
  • Editors

General Information

  • Advertisers
  • Subscribers
  • Rights and Permissions
  • Accessibility Statement
  • FAR 889
  • Privacy Policy
  • Disclaimer

Journal Services

  • Email Alerts
  • RSS Feeds
  • ImmunoCasts
  • Twitter

Copyright © 2022 by The American Association of Immunologists, Inc.

Print ISSN 0022-1767        Online ISSN 1550-6606